Tai, Wei-Tien <br/><br/>
Discovery of novel Src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma.  [electronic resource] 

 -  Hepatology (Baltimore, Md.)  Jan 2014 
 - 190-201 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-3350 
<br/><br/><label>Standard No.: </label>10.1002/hep.26640  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Carcinoma, Hepatocellular--drug therapy<br/>Catalytic Domain<br/>Cell Line, Tumor<br/>Drug Resistance, Neoplasm--drug effects<br/>Humans<br/>Liver Neoplasms--drug therapy<br/>Mice<br/>Models, Molecular<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds--pharmacology<br/>Protein Tyrosine Phosphatase, Non-Receptor Type 6--chemistry<br/>Random Allocation<br/>STAT3 Transcription Factor--antagonists & inhibitors<br/>Sorafenib<br/>Xenograft Model Antitumor Assays